The impact of evidence-based medicine on diabetes therapy

被引:1
|
作者
Phillip Gorden
Carla Musso
机构
[1] NIDDK,Clinical Endocrinology Branch
[2] National Institutes of Health,undefined
关键词
Metformin; Captopril; Irbesartan; Early Treatment Diabetic Retinopathy Study; Invite Commentary;
D O I
10.1007/s11892-005-0001-8
中图分类号
学科分类号
摘要
引用
收藏
页码:157 / 159
页数:2
相关论文
共 50 条
  • [1] The impact of evidence-based medicine on policy
    Sox, H
    EVIDENCE-BASED MEDICINE: A CRITICAL ASSESSMENT, 2002, 252 : 1 - 16
  • [2] An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment
    Makam, Anil N.
    Nguyen, Oanh K.
    CIRCULATION, 2017, 135 (02) : 180 - 195
  • [3] Orthopedic pain therapy and evidence-based medicine
    Krämer, J
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 1999, 137 (04): : OA6 - OA7
  • [4] Antioxidant therapy in uremia: Evidence-based medicine?
    Gordon, CA
    Himmelfarb, J
    SEMINARS IN DIALYSIS, 2004, 17 (05) : 327 - 332
  • [5] Evidence-based medicine hits group therapy
    Lonergan, EC
    INTERNATIONAL JOURNAL OF GROUP PSYCHOTHERAPY, 2000, 50 (01) : 105 - 112
  • [6] Evidence-based medicine and hormone replacement therapy
    Alkhenizan, A
    ANNALS OF SAUDI MEDICINE, 2004, 24 (03) : 164 - 165
  • [7] Evidence-based Chinese medicine for cancer therapy
    Konkimalla, V. Badireenath
    Efferth, Thomas
    JOURNAL OF ETHNOPHARMACOLOGY, 2008, 116 (02) : 207 - 210
  • [8] Impact of a novel evidence-based medicine curriculum
    McMahon, GT
    Dluhy, RG
    MEDICAL EDUCATION, 2006, 40 (05) : 464 - 465
  • [9] Evidence-Based Medicine and the Selection of Lipid-Lowering Therapy in Type 2 Diabetes
    Carlos A. Aguilar-Salinas
    Roopa Mehta
    Rita A. Gomez-Diaz
    Current Diabetes Reports, 2012, 12 : 221 - 223
  • [10] Evidence-Based Medicine and the Selection of Lipid-Lowering Therapy in Type 2 Diabetes
    Aguilar-Salinas, Carlos A.
    Mehta, Roopa
    Gomez-Diaz, Rita A.
    CURRENT DIABETES REPORTS, 2012, 12 (03) : 221 - 223